Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of β1 Adrenoceptor Agonists market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of β1 Adrenoceptor Agonistsmarket, defines the market attractiveness level of β1 Adrenoceptor Agonists market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of β1 Adrenoceptor Agonists industry, describes the types of β1 Adrenoceptor Agonists market, the applications of major players and the market size, and deeply analyzes the current situation of the global β1 Adrenoceptor Agonists market and the development prospects and opportunities of β1 Adrenoceptor Agonists industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global β1 Adrenoceptor Agonists market in Chapter 13.
By Player:
Baxter Healthcare
Sterimax
Teva Canada
Pfizer
Physicians Total Care
Bedford Laboratories
Teligent
Novartis
Ivax Pharmaceuticals
Sanofi
By Type:
Dobutamine
Denopamine
Xamoterol
Others
By End-User:
Chronic Heart Failure
Myocardial Infarction
Postoperative Hypotension
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 β1 Adrenoceptor Agonists Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 β1 Adrenoceptor Agonists Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 β1 Adrenoceptor Agonists Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 β1 Adrenoceptor Agonists Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise β1 Adrenoceptor Agonists Market Analysis and Outlook to 2022
-
7.1 Global β1 Adrenoceptor Agonists Consumption (2017-2022)
-
7.2 United States β1 Adrenoceptor Agonists Consumption (2017-2022)
-
7.3 Europe β1 Adrenoceptor Agonists Consumption (2017-2022)
-
7.4 China β1 Adrenoceptor Agonists Consumption (2017-2022)
-
7.5 Japan β1 Adrenoceptor Agonists Consumption (2017-2022)
-
7.6 India β1 Adrenoceptor Agonists Consumption (2017-2022)
-
7.7 South Korea β1 Adrenoceptor Agonists Consumption (2017-2022)
8 Region and Country-wise β1 Adrenoceptor Agonists Market Analysis and Outlook to 2028
-
8.1 Global β1 Adrenoceptor Agonists Consumption Forecast (2022-2028)
-
8.2 United States β1 Adrenoceptor Agonists Consumption Forecast (2022-2028)
-
8.3 Europe β1 Adrenoceptor Agonists Consumption Forecast (2022-2028)
-
8.4 China β1 Adrenoceptor Agonists Consumption Forecast (2022-2028)
-
8.5 Japan β1 Adrenoceptor Agonists Consumption Forecast (2022-2028)
-
8.6 India β1 Adrenoceptor Agonists Consumption Forecast (2022-2028)
-
8.7 South Korea β1 Adrenoceptor Agonists Consumption Forecast (2022-2028)
9 Global β1 Adrenoceptor Agonists Market Outlook by Types and Applications to 2022
-
9.1 Global β1 Adrenoceptor Agonists Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Dobutamine Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Denopamine Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Xamoterol Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global β1 Adrenoceptor Agonists Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Chronic Heart Failure Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Myocardial Infarction Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Postoperative Hypotension Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global β1 Adrenoceptor Agonists Market Outlook by Types and Applications to 2028
-
10.1 Global β1 Adrenoceptor Agonists Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Dobutamine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Denopamine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Xamoterol Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global β1 Adrenoceptor Agonists Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Chronic Heart Failure Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Myocardial Infarction Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Postoperative Hypotension Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global β1 Adrenoceptor Agonists Import and Export Analysis (Top 5 Countries)
-
11.1 Global β1 Adrenoceptor Agonists Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global β1 Adrenoceptor Agonists Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 β1 Adrenoceptor Agonists Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global β1 Adrenoceptor Agonists Market Competitive Analysis
-
14.1 Baxter Healthcare
-
14.1.1 Baxter Healthcare Company Details
-
14.1.2 Baxter Healthcare β1 Adrenoceptor Agonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Baxter Healthcare β1 Adrenoceptor Agonists Product and Service
-
14.2 Sterimax
-
14.2.1 Sterimax Company Details
-
14.2.2 Sterimax β1 Adrenoceptor Agonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Sterimax β1 Adrenoceptor Agonists Product and Service
-
14.3 Teva Canada
-
14.3.1 Teva Canada Company Details
-
14.3.2 Teva Canada β1 Adrenoceptor Agonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Teva Canada β1 Adrenoceptor Agonists Product and Service
-
14.4 Pfizer
-
14.4.1 Pfizer Company Details
-
14.4.2 Pfizer β1 Adrenoceptor Agonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Pfizer β1 Adrenoceptor Agonists Product and Service
-
14.5 Physicians Total Care
-
14.5.1 Physicians Total Care Company Details
-
14.5.2 Physicians Total Care β1 Adrenoceptor Agonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Physicians Total Care β1 Adrenoceptor Agonists Product and Service
-
14.6 Bedford Laboratories
-
14.6.1 Bedford Laboratories Company Details
-
14.6.2 Bedford Laboratories β1 Adrenoceptor Agonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Bedford Laboratories β1 Adrenoceptor Agonists Product and Service
-
14.7 Teligent
-
14.7.1 Teligent Company Details
-
14.7.2 Teligent β1 Adrenoceptor Agonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Teligent β1 Adrenoceptor Agonists Product and Service
-
14.8 Novartis
-
14.8.1 Novartis Company Details
-
14.8.2 Novartis β1 Adrenoceptor Agonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Novartis β1 Adrenoceptor Agonists Product and Service
-
14.9 Ivax Pharmaceuticals
-
14.9.1 Ivax Pharmaceuticals Company Details
-
14.9.2 Ivax Pharmaceuticals β1 Adrenoceptor Agonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Ivax Pharmaceuticals β1 Adrenoceptor Agonists Product and Service
-
14.10 Sanofi
-
14.10.1 Sanofi Company Details
-
14.10.2 Sanofi β1 Adrenoceptor Agonists Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Sanofi β1 Adrenoceptor Agonists Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of β1 Adrenoceptor Agonists
-
Figure β1 Adrenoceptor Agonists Picture
-
Table Global β1 Adrenoceptor Agonists Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global β1 Adrenoceptor Agonists Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global β1 Adrenoceptor Agonists Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global β1 Adrenoceptor Agonists Consumption by Country (2017-2022)
-
Figure United States β1 Adrenoceptor Agonists Consumption and Growth Rate (2017-2022)
-
Table Europe β1 Adrenoceptor Agonists Consumption and Growth Rate (2017-2022)
-
Figure China β1 Adrenoceptor Agonists Consumption and Growth Rate (2017-2022)
-
Figure Japan β1 Adrenoceptor Agonists Consumption and Growth Rate (2017-2022)
-
Figure India β1 Adrenoceptor Agonists Consumption and Growth Rate (2017-2022)
-
Figure South Korea β1 Adrenoceptor Agonists Consumption and Growth Rate (2017-2022)
-
Figure Global β1 Adrenoceptor Agonists Consumption Forecast by Country (2022-2028)
-
Figure United States β1 Adrenoceptor Agonists Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe β1 Adrenoceptor Agonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure China β1 Adrenoceptor Agonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan β1 Adrenoceptor Agonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure India β1 Adrenoceptor Agonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea β1 Adrenoceptor Agonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dobutamine Consumption and Growth Rate (2017-2022)
-
Figure Global Denopamine Consumption and Growth Rate (2017-2022)
-
Figure Global Xamoterol Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Chronic Heart Failure Consumption and Growth Rate (2017-2022)
-
Figure Global Myocardial Infarction Consumption and Growth Rate (2017-2022)
-
Figure Global Postoperative Hypotension Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Dobutamine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Denopamine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Xamoterol Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chronic Heart Failure Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Myocardial Infarction Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Postoperative Hypotension Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global β1 Adrenoceptor Agonists Import by Region (Top 5 Countries) (2017-2028)
-
Table Global β1 Adrenoceptor Agonists Export by Region (Top 5 Countries) (2017-2028)
-
Table Baxter Healthcare (Foundation Year, Company Profile and etc.)
-
Table Baxter Healthcare β1 Adrenoceptor Agonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Baxter Healthcare β1 Adrenoceptor Agonists Product and Service
-
Table Sterimax (Foundation Year, Company Profile and etc.)
-
Table Sterimax β1 Adrenoceptor Agonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sterimax β1 Adrenoceptor Agonists Product and Service
-
Table Teva Canada (Foundation Year, Company Profile and etc.)
-
Table Teva Canada β1 Adrenoceptor Agonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Canada β1 Adrenoceptor Agonists Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer β1 Adrenoceptor Agonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer β1 Adrenoceptor Agonists Product and Service
-
Table Physicians Total Care (Foundation Year, Company Profile and etc.)
-
Table Physicians Total Care β1 Adrenoceptor Agonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Physicians Total Care β1 Adrenoceptor Agonists Product and Service
-
Table Bedford Laboratories (Foundation Year, Company Profile and etc.)
-
Table Bedford Laboratories β1 Adrenoceptor Agonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bedford Laboratories β1 Adrenoceptor Agonists Product and Service
-
Table Teligent (Foundation Year, Company Profile and etc.)
-
Table Teligent β1 Adrenoceptor Agonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teligent β1 Adrenoceptor Agonists Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis β1 Adrenoceptor Agonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis β1 Adrenoceptor Agonists Product and Service
-
Table Ivax Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Ivax Pharmaceuticals β1 Adrenoceptor Agonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ivax Pharmaceuticals β1 Adrenoceptor Agonists Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi β1 Adrenoceptor Agonists Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi β1 Adrenoceptor Agonists Product and Service
-
